Positive Topline Phase 3 Data for Lecanemab in Early Alzheimer's
The antiamyloid lecanemab significantly reduced brain amyloid and cognitive decline in adults with early AD in the phase 3 Clarity AD trial.
Source: medscape.com
Page 36 - Mci News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mci. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mci Today - Breaking & Trending Today
Not Just a Bad Dream: Nightmares May Predict Dementia
Frequent bad dreams during middle and older age may accelerate cognitive decline and increase risk for dementia, especially in men, new research suggests.
Source: medscape.com
Improved Screening for Post-op Delirium Holds Promise
Older adults are more likely to experience delirium after surgery, but a new study found effective screening can reduce their chances of developing the complication.
Source: medscape.com
Exercise May Help Restore Function in MS-Related Thalamic Atrophy
Aerobic exercise has the potential to restore function in adults with MS and thalamic atrophy — a patient population at increased risk for progressive physical and cognitive decline.
Source: medscape.com
Risk Prediction Models Identify Presymptomatic Alzheimer's Disease
Risk models based on noncognitive measures may predict presymptomatic Alzheimer's disease.
Source: medscape.com